Status: current, Defined. Date: 31-May 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4814471000168110 | Apretude (cabotegravir 600 mg / 3 mL) modified release injection, 25 x 3 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4814481000168113 | Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | Is a | cabotegravir 600 mg/3 mL modified release injection, 25 x 3 mL vials | true | Inferred relationship | Some | ||
| Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | has TP | Apretude | true | Inferred relationship | Some | ||
| Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | has TPUU | Apretude 600 mg/3 mL modified release injection, 3 mL vial | true | Inferred relationship | Some | 1327565371 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | Is a | True | Apretude 600 mg/3 mL modified release injection, 25 x 3 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR